These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 15543085

  • 1. Inhibition of human plasma leucine5-enkephalin aminopeptidase hydrolysis by various endogenous peptides and a select number of clinically used drugs.
    Mosnaim AD, Puente J, Ranade V, Hoang C, Wolf ME.
    Am J Ther; 2004; 11(6):459-65. PubMed ID: 15543085
    [Abstract] [Full Text] [Related]

  • 2. In vitro human plasma leucine(5)-enkephalin degradation is inhibited by a select number of drugs with the phenothiazine molecule in their chemical structure.
    Mosnaim AD, Puente J, Saavedra R, Diamond S, Wolf ME.
    Pharmacology; 2003 Jan; 67(1):6-13. PubMed ID: 12444298
    [Abstract] [Full Text] [Related]

  • 3. Bacitracin-sensitive aminopeptidase(s) degradation of methionine(5)-enkephalin by human brain putamen and hippocampus preparations: inhibition by phenothiazine drugs.
    Mosnaim AD, Saavedra R, Wolf ME.
    Am J Ther; 2009 Jan; 16(6):512-6. PubMed ID: 19797941
    [Abstract] [Full Text] [Related]

  • 4. Degradation kinetics of leucine5-enkephalin by plasma samples from healthy controls and various patient populations: in vitro drug effects.
    Mosnaim AD, Wolf ME, Nguyen TD, Puente J, Freitag F, Diamond S.
    Am J Ther; 2000 May; 7(3):185-94. PubMed ID: 11317167
    [Abstract] [Full Text] [Related]

  • 5. Identification and characterization of aminopeptidases from Aplysia californica.
    Bawab W, Querido E, Crine P, DesGroseillers L.
    Biochem J; 1992 Sep 15; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
    [Abstract] [Full Text] [Related]

  • 6. Enkephalin hydrolysis by mouse plasma in vitro.
    Shibanoki S, Weinberger SB, Schulteis G, Ishikawa K, Martinez JL.
    Life Sci; 1992 Sep 15; 50(10):667-75. PubMed ID: 1346713
    [Abstract] [Full Text] [Related]

  • 7. Hydrolysis of [Leu]enkephalin by chick plasma in vitro.
    Shibanoki S, Weinberger SB, Beniston D, Nudelman KA, Schulteis G, Bennett EL, Rosenzweig MR, Ishikawa K, Martinez JL.
    J Pharmacol Exp Ther; 1991 Feb 15; 256(2):650-5. PubMed ID: 1994000
    [Abstract] [Full Text] [Related]

  • 8. Characterization of hydrolysis of [leu]enkephalin and D-ala2-[L-leu]enkephalin in rat plasma.
    Weinberger SB, Martinez JL.
    J Pharmacol Exp Ther; 1988 Oct 15; 247(1):129-35. PubMed ID: 2902210
    [Abstract] [Full Text] [Related]

  • 9. Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin.
    Cohen ML, Geary LE, Wiley KS.
    J Pharmacol Exp Ther; 1983 Feb 15; 224(2):379-85. PubMed ID: 6822962
    [Abstract] [Full Text] [Related]

  • 10. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
    Giros B, Gros C, Solhonne B, Schwartz JC.
    Mol Pharmacol; 1986 Mar 15; 29(3):281-7. PubMed ID: 2869404
    [Abstract] [Full Text] [Related]

  • 11. Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M.
    Bausback HH, Ward PE.
    Biochim Biophys Acta; 1986 Jul 16; 882(3):437-44. PubMed ID: 2873842
    [Abstract] [Full Text] [Related]

  • 12. Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues.
    Friedman DI, Amidon GL.
    Pharm Res; 1991 Jan 16; 8(1):93-6. PubMed ID: 2014216
    [Abstract] [Full Text] [Related]

  • 13. The aminopeptidase activity in the human T-cell lymphoma line (Jurkat) is not at the cell surface and is not aminopeptidase N (CD-13).
    Murray H, Turner AJ, Kenny AJ.
    Biochem J; 1994 Mar 01; 298 ( Pt 2)(Pt 2):353-60. PubMed ID: 7907864
    [Abstract] [Full Text] [Related]

  • 14. Characterization of enkephalin degradation in rat plasma.
    Weinberger SB, Zafuto CE, Walker RC, Martinez JL.
    NIDA Res Monogr; 1986 Mar 01; 75():263-6. PubMed ID: 3123942
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms protecting plasma peptides from enzyme hydrolysis: a comparative study.
    Venturelli F, Roscetti G, Roda LG.
    Comp Biochem Physiol B; 1987 Mar 01; 87(3):485-8. PubMed ID: 3621910
    [Abstract] [Full Text] [Related]

  • 16. Further characterization of the in vitro hydrolysis of [Leu]- and [Met]enkephalin in rat plasma: HPLC-ECD measurement of substrate and metabolite concentrations.
    Shibanoki S, Weinberger SB, Ishikawa K, Martinez JL.
    Regul Pept; 1991 Feb 26; 32(3):267-78. PubMed ID: 1678195
    [Abstract] [Full Text] [Related]

  • 17. Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta.
    Robertson MJ, Cunoosamy MP, Clark KL.
    Br J Pharmacol; 1992 May 26; 106(1):166-72. PubMed ID: 1354540
    [Abstract] [Full Text] [Related]

  • 18. N-terminal degradation of low molecular weight opioid peptides in human cerebrospinal fluid.
    Benter IF, Hirsh EM, Tuchman AJ, Ward PE.
    Biochem Pharmacol; 1990 Aug 01; 40(3):465-72. PubMed ID: 1974424
    [Abstract] [Full Text] [Related]

  • 19. Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M.
    Palmieri FE, Bausback HH, Ward PE.
    Biochem Pharmacol; 1989 Jan 01; 38(1):173-80. PubMed ID: 2462880
    [Abstract] [Full Text] [Related]

  • 20. [Some features of enkephalin metabolism in the rat brain after administration of bestatin].
    Beliaev NA, Kolesanova EF, Baronets VIu, Panchenko LF.
    Biokhimiia; 1993 Jul 01; 58(7):1033-46. PubMed ID: 8364122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.